-
1
-
-
0027478091
-
In vitro antimicrobial activity of CP-99, 219, a novel azabicyclo-naphthyridone
-
Briggs Gooding, B. and R. N. Jones: In vitro antimicrobial activity of CP-99, 219, a novel azabicyclo-naphthyridone. Antimicrob. Agents Chemother. 37 (1993) 349-353
-
(1993)
Antimicrob. Agents Chemother.
, vol.37
, pp. 349-353
-
-
Briggs Gooding, B.1
Jones, R.N.2
-
2
-
-
0029144805
-
The in-vitro activity of CP 99, 219, a new naphthyridone antimicrobial agent: A comparison with fluoroquinolone agents
-
Child, J., J. Andrews, F. Boswell, N. Brenwald, and R. Wise: The in-vitro activity of CP 99, 219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents. J. Antimicrob. Chemother. 35 (1995) 869-876
-
(1995)
J. Antimicrob. Chemother.
, vol.35
, pp. 869-876
-
-
Child, J.1
Andrews, J.2
Boswell, F.3
Brenwald, N.4
Wise, R.5
-
3
-
-
0029903277
-
Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99, 219) against gram-positive cocci
-
Coque, T. M., K. V. Singh, and B. E. Murray: Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99, 219) against gram-positive cocci. J. Antimicrob. Chemother. 37 (1996) 1011-1016
-
(1996)
J. Antimicrob. Chemother.
, vol.37
, pp. 1011-1016
-
-
Coque, T.M.1
Singh, K.V.2
Murray, B.E.3
-
4
-
-
0027528541
-
In vitro activity of CP 99, 219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria
-
Eliopoulos, G. M., K. Klimm, C. T. Eliopoulos, M. J. Ferraro, and R. C. Moellering, Jr.: In vitro activity of CP 99, 219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria. Antimicrob. Agents Chemother. 37 (1993) 366-370
-
(1993)
Antimicrob. Agents Chemother.
, vol.37
, pp. 366-370
-
-
Eliopoulos, G.M.1
Klimm, K.2
Eliopoulos, C.T.3
Ferraro, M.J.4
Moellering Jr., R.C.5
-
5
-
-
0031001953
-
Comparative in vitro activities of trovafloxacin (CP-99, 219) against 445 gram-positive isolates from patients with endocarditis and those with other blood-stream infections
-
Endtz, H. P., J. W. Mouton, J. G. den Hollander, N. van den Braak, and H. A. Verbrugh: Comparative in vitro activities of trovafloxacin (CP-99, 219) against 445 gram-positive isolates from patients with endocarditis and those with other blood-stream infections. Antimicrob. Agents Chemother. 41 (1997) 1146-1149
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 1146-1149
-
-
Endtz, H.P.1
Mouton, J.W.2
Den Hollander, J.G.3
Van Den Braak, N.4
Verbrugh, H.A.5
-
6
-
-
0002977684
-
Enterobacteriaceae: Introduction and identification
-
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), American Society for Microbiology. Washington, D.C.
-
Farmer, J. J. III.: Enterobacteriaceae: introduction and identification, p. 438-449. In: P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology. Washington, D.C. (1995)
-
(1995)
Manual of Clinical Microbiology, 6th Ed.
, pp. 438-449
-
-
Farmer III, J.J.1
-
7
-
-
0029162048
-
Activity of quinolones against gram-positive cocci: Clinical features
-
Giamarellou, H.: Activity of quinolones against gram-positive cocci: clinical features. Drugs 49 (Suppl. 2) (1995) 58-66
-
(1995)
Drugs
, vol.49
, Issue.2 SUPPL.
, pp. 58-66
-
-
Giamarellou, H.1
-
8
-
-
85030357028
-
Pseudomonas and Burkbolderia
-
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), American Society for Microbiology. Washington, D. C.
-
Gilligan, P. H.: Pseudomonas and Burkbolderia, p. 509-519. In: P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology. Washington, D. C.
-
Manual of Clinical Microbiology, 6th Ed.
, pp. 509-519
-
-
Gilligan, P.H.1
-
9
-
-
0028117869
-
In-vitro activity of CP-99, 219, a novel 7 (3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial
-
Gootz, T. D., K. E. Brighty, M. R. Anderson, B. J. Schmieder, S. L. Haskell, J. A. Sutcliffe, M. J. Castaldi, and P. R. McGuirk: In-vitro activity of CP-99, 219, a novel 7 (3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial. Diagn. Microbiol. Infect. Dis. 19 (1994) 235-243
-
(1994)
Diagn. Microbiol. Infect. Dis.
, vol.19
, pp. 235-243
-
-
Gootz, T.D.1
Brighty, K.E.2
Anderson, M.R.3
Schmieder, B.J.4
Haskell, S.L.5
Sutcliffe, J.A.6
Castaldi, M.J.7
McGuirk, P.R.8
-
10
-
-
0009648982
-
Double blind, randomized, multicenter study of nosocomial pseunomia (NOS) comparing trovafloaxin with ciprofloxacin ± clindamycin/metronidazole
-
abstr. LM-74, American Society for Microbiology, Washington, D. C.
-
Graham, D. R., T. Klein, A. Torres, M. Niedermann, and the Torvan Nosocomial Pneumonia Study Group: Double blind, randomized, multicenter study of nosocomial pseunomia (NOS) comparing trovafloaxin with ciprofloxacin ± clindamycin/metronidazole, abstr. LM-74, p.378. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D. C.
-
Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy
, pp. 378
-
-
Graham, D.R.1
Klein, T.2
Torres, A.3
Niedermann, M.4
-
11
-
-
0029818220
-
Antibacterial activity of trovafloxacin against Gram-positive blood culture isolates from nosocomial infections
-
Hussain Qadri, S. M. and Y. Ueno: Antibacterial activity of trovafloxacin against Gram-positive blood culture isolates from nosocomial infections. Eur. J. Clin. Microbiol. Infect. Dis. 15 (1996) 694-696
-
(1996)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.15
, pp. 694-696
-
-
Hussain Qadri, S.M.1
Ueno, Y.2
-
12
-
-
0002870339
-
Staphylococcus and Micrococcus
-
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), American Society for Microbiology, Washington, D.C.
-
Kloos, W. E. and T. L. Bannerman: Staphylococcus and Micrococcus, p.282-298. In: P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C. (1995)
-
(1995)
Manual of Clinical Microbiology, 6th Ed.
, pp. 282-298
-
-
Kloos, W.E.1
Bannerman, T.L.2
-
13
-
-
0002448786
-
Efficacy of trovafloxacin in patients with community acquired pneumonia due to penicillin susceptible and resistant S. pneumoniae
-
abstr. LM-71, American Society for Microbiology, Washington, D. C.
-
Mandell, L., D. W. Hopkins, and S. Hopkins: Efficacy of trovafloxacin in patients with community acquired pneumonia due to penicillin susceptible and resistant S. pneumoniae, abstr. LM-71, p. 377. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D. C. (1997)
-
(1997)
Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy
, pp. 377
-
-
Mandell, L.1
Hopkins, D.W.2
Hopkins, S.3
-
14
-
-
0025753375
-
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lympomas and solid tumors
-
Meunier, F., S. H. Zinner, H. Gaya, T. Calandra, C. Viscoli, J. Klastersky, M. Glauser, and the European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group: Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lympomas and solid tumors. Antimicrob. Agents Chemother. 35 (1991) 873-878
-
(1991)
Antimicrob. Agents Chemother.
, vol.35
, pp. 873-878
-
-
Meunier, F.1
Zinner, S.H.2
Gaya, H.3
Calandra, T.4
Viscoli, C.5
Klastersky, J.6
Glauser, M.7
-
15
-
-
0037710633
-
-
Approved standard. NCCLS publication no. M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa
-
National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Approved standard. NCCLS publication no. M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa (1997)
-
(1997)
Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 4th Ed.
-
-
-
16
-
-
0027999053
-
Activity of CP 99, 219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against 489 anaerobes
-
Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum: Activity of CP 99, 219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against 489 anaerobes. Antimicrob. Agents Chemother. 38 (1994) 2471-2476
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 2471-2476
-
-
Spangler, S.K.1
Jacobs, M.R.2
Appelbaum, P.C.3
-
17
-
-
0030756870
-
The in-vitro activity of trovafloxacin, a new fluoroquinolone, against gram-positive bacteria
-
Sefton, A. M., J. P. Maskell, A. M. Rafay, A. Wholey, and J. D. Williams: The in-vitro activity of trovafloxacin, a new fluoroquinolone, against gram-positive bacteria. J. Antimicrob. Chemother. 39 (Suppl. B.) (1997) 57-62
-
(1997)
J. Antimicrob. Chemother.
, vol.39
, Issue.SUPPL. B.
, pp. 57-62
-
-
Sefton, A.M.1
Maskell, J.P.2
Rafay, A.M.3
Wholey, A.4
Williams, J.D.5
-
18
-
-
0029092852
-
Pharmacokinetics and safety of trovafloxacin (CP 99, 219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers
-
Teng, R., S. C. .Harris, D. E. Nix, J. J. Schentag, G. Foulds, and T. E. Liston: Pharmacokinetics and safety of trovafloxacin (CP 99, 219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers. J. Antimicrob. Chemother. 36 (1995) 385-394
-
(1995)
J. Antimicrob. Chemother.
, vol.36
, pp. 385-394
-
-
Teng, R.1
Harris, S.C.2
Nix, D.E.3
Schentag, J.J.4
Foulds, G.5
Liston, T.E.6
-
19
-
-
0030845019
-
Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods
-
Visalli, M. A., S. Bajaksouzian, M. R. Jacobs, and P. C. Appelbaum: Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods. Antimicrob. Agents Chemother. 41 (1997) 1475-1481
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 1475-1481
-
-
Visalli, M.A.1
Bajaksouzian, S.2
Jacobs, M.R.3
Appelbaum, P.C.4
|